BioSpace News Archive

Business

Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine

Flagship Pioneering, the bioplatform innovation company, and Samsung announced a collaboration aimed at fostering cutting-edge biopharmaceutical innovation poised to transform the world of healthcare through groundbreaking advancements in translational science and medicine.

January 8, 2024
·
3 min read
Genetown

Nuvalent Announces “OnTarget 2026" Operating Plan and Key Anticipated Milestones

Nuvalent, Inc. announced its “OnTarget 2026" operating plan to guide efforts towards having its first potential approved product in 2026.

January 8, 2024
·
10 min read
Genetown

Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference

Sage Therapeutics, Inc. announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

January 8, 2024
·
9 min read
Genetown

Sage Therapeutics Announces Changes to Board of Directors - Jan 08, 2024

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced the retirement of Kevin Starr from the company’s board of directors.

January 8, 2024
·
2 min read
Bio NC

G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference

G1 Therapeutics, Inc. announced new clinical, commercial and corporate updates, including encouraging preliminary overall survival data from the Company’s ongoing Phase 2 trial of trilaciclib in combination with the ADC sacituzumab govitecan in patients with TNBC.

January 8, 2024
·
7 min read
Bio NC

Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and patient, provided a preliminary 2023 year-end corporate update.

January 8, 2024
·
10 min read
Drug Development

Biosion’s Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC)

The Partner of Biosion Inc., OBI Pharma, announced that the U.S. Food and Drug Administration has cleared an investigational new drug application for OBI-992, to conduct a Phase 1/2 study of its novel antibody drug conjugate cancer therapy targeting TROP2.

January 8, 2024
·
4 min read
Medtronic Diabetes announces world’s first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor

Medtronic plc, a global leader in healthcare technology, announced CE Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable, all-in-one continuous glucose monitor requiring no fingersticks or overtape.

January 8, 2024
·
6 min read
Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company

Domain Therapeutics announces the appointments of Michael Gottlieb, as its Chairman of the Board of Directors, and Anthony Johnson, M.D., as its President and Chief Executive Officer.

January 8, 2024
·
3 min read
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

LSL Pharma Group Inc. announces that it extends until February 7, 2024 its brokered private placement through the issuance of unsecured convertible debentures at a price of $10 per debenture.

January 8, 2024
·
3 min read